Probing the signaling requirements for naive human pluripotency by high-throughput chemical screening
2021 · Cell Reports · 61 citations
https://doi.org/10.1016/j.celrep.2021.109233
D
Dominick Casalena
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
14
Papers
323
Citations
9
h-index
8
i10-index
Dominick Casalena is an academic researcher from Novartis (United States). The author has contributed to research in topics: Monoclonal and Polyclonal Antibodies Research & HIV Research and Treatment & Cancer, Hypoxia, and Metabolism. The author has an h-index of 9, co-authored 12 publications.
Papers by this author
worksIdentification and validation of selective deubiquitinase inhibitors
2021 · Cell chemical biology · 36 citations
https://doi.org/10.1016/j.chembiol.2021.05.012
Identification of deubiquitinase inhibitors via high-throughput screening using a fluorogenic ubiquitin-rhodamine assay
2021 · STAR Protocols · 8 citations
https://doi.org/10.1016/j.xpro.2021.100896
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat